| Japanese | English |
| Information | |
| Organization: | Fujita Health University School of Medicine |
| NAMEF | Division of Cardiology |
| HomePage: | http://www.junkanki.fujita-hu.jp/ |
| STAFF | |||
| chief professor | Hitoshi Hishida | ||
| professor | Shinichiro Morimoto | ||
| professor | Masatsugu Iwase | ||
| associate professor | Yukio Ozaki | ||
| associate professor | Shinya Hiramitsu | ||
| associate professor | Masatsugu Otsuki | ||
| assistant professor | Eiichi Watanabe | ||
| assistant professor | Masayoshi Sarai | ||
| assistant professor | Shigeru Kato | ||
| assistant professor | Yasuchika Kato | ||
| assistant professor | Shigeru Matsui | ||
| assistant professor | Sadako Motoyama | ||
| assistant professor | Hiroyuki Naruse | ||
| assistant professor | Tatsushi Uchiyama | ||
| assistant professor | Takahisa Sato | ||
| History |
| The division of cardiology was established in 1973. Dr. Yasushi Mizuno assumed the first chief professor of cardiology. CCU was inaugurated in 1979. Currently, There are two educational hospital. |
| research |
| We mostly focus our research on clinical aspect.
1. New phamacotherapy of heart failure 2. Molecular biology of heat failure 3. Study of clock gene by ambulatory ECG analysis 4. Stress cardiac echo 5. IVUS for coronary atherosclerosis 6. Biochemical marker for myocardial injury 7. Non-invasive imaging (CT, MRI) for coronary artery and myocardial damage (CT, MRI, SPECT) |
| clinical aspect |
| The number of patient beds is 80 including 70 in general wards and 10 in CCU. The number of inpatients is about 80 per day, and outpatients is about 120 per day. We treat about 150 patients with acute coronary syndrome (ACS) per year. Our division deal with all cardiovascular diseases. The number of staff cardiologists is about 30.
Diagnosis and treatment of cardiovascular diseases involves various tests including non-ivasive and invasive. The former includes ECG, ultrasound (4406/year), stress ECG test(339/year), SPECT(700/year), cardiac MRI and coronary CTA (200/year). The latter includes CAG (1130/year). We are introducing new treatments for cardiovascular disease. Not only new phamacotherapy, but also PCI (400/year), implantation of artificial pacemaker (60/year) and catheter ablation (70/year). |
Tue Oct 31 23:02:43 JST 2006